Fecal Microbiota Characteristics in Constipation-Predominant and Mixed-Type Irritable Bowel Syndrome
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(7), P. 1414 - 1414
Published: July 12, 2024
Irritable
bowel
syndrome
(IBS)
is
a
common
condition
that
affects
the
lifestyle
of
patients.
It
associated
with
significant
changes
in
composition
gut
microbiome,
but
underlying
microbial
mechanisms
remain
to
be
fully
understood.
We
study
fecal
microbiome
patients
constipation-predominant
IBS
(IBS-C)
and
mixed-type
(IBS-M).
Language: Английский
Function and therapeutic potential of Amuc_1100, an outer membrane protein of Akkermansia muciniphila: A review
Xuhui Wu,
No information about this author
Dahai Yu,
No information about this author
Yixuan Ma
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142442 - 142442
Published: March 1, 2025
Language: Английский
The Impact of Diet on the Colonization of Beneficial Microbes from an Ecological Perspective
Zelin Chen,
No information about this author
Chuntao Xiao,
No information about this author
Jintun Zhang
No information about this author
et al.
Journal of Agricultural and Food Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 15, 2025
With
growing
recognition
of
the
pivotal
role
gut
microbiota
in
human
health,
probiotics
have
gained
widespread
attention
for
their
potential
to
restore
microbial
homeostasis.
However,
a
critical
challenge
persists:
limited
colonization
efficiency
among
most
probiotic
strains
compromises
therapeutic
efficacy.
This
overview
synthesizes
ecological
principles
with
cutting-edge
microbiome
research
elucidate
dynamic
interplay
between
dietary
components
and
within
intestinal
niche.
systematically
analyzes:
(1)
stage-specific
mechanisms
spanning
introduction,
establishment,
proliferation;
(2)
nutrient-driven
modulation
composition
function;
(3)
dual
common
patterns
as
both
facilitators
disruptors
persistence.
Notably,
this
identifies
key
strategies,
including
precision
delivery
prebiotic
fibers
polyphenol-microbiota
crosstalk,
that
enhance
niche
adaptation
through
pH
optimization,
adhesion
potentiation,
competitive
exclusion
pathogens.
Furthermore,
critically
evaluates
current
limitations
research,
particularly
strain-specific
variability
methodological
constraints
simulating
host-microbe-diet
tripartite
interactions.
To
bridge
these
gaps,
proposes
an
interdisciplinary
framework
integrating
omics-driven
strain
selection,
engineered
systems,
personalized
nutrition
models.
Collectively,
work
advances
mechanistic
understanding
diet-microbiota
interactions
while
providing
actionable
insights
developing
targeted
therapies
evidence-based
interventions
optimize
ecosystem
resilience.
Language: Английский
Broad-Spectrum Antibacterial Activity of Antioxidant Octyl Gallate and Its Impact on Gut Microbiome
Junshu Yang,
No information about this author
Trevor J. Gould,
No information about this author
Byeonghwa Jeon
No information about this author
et al.
Antibiotics,
Journal Year:
2024,
Volume and Issue:
13(8), P. 731 - 731
Published: Aug. 4, 2024
In
this
study,
we
investigated
the
antibacterial
activity
of
octyl
gallate
(OG),
an
antioxidant
food
additive,
against
both
Gram-positive
and
Gram-negative
bacterial
pathogens.
OG
demonstrated
robust
bactericidal
pathogens
with
minimum
inhibitory
concentrations
(MIC)
4
to
8
µg/mL
(MBC)
16
in
vitro.
However,
exhibited
limited
bacteria,
including
Language: Английский
Akkermansia muciniphila helps in the recovery of lipopolysaccharide-fed mice with mild intestinal dysfunction
Yue Hu,
No information about this author
Jun Zhou,
No information about this author
Xiaoqi Lin
No information about this author
et al.
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 12, 2025
Background
Mild
intestinal
dysfunction,
linked
to
subtle
yet
significant
health
issues,
can
be
induced
by
lipopolysaccharide
(LPS),
a
Gram-negative
bacterial
component
that
disrupts
gut
function
and
triggers
inflammation.
Akkermansia
muciniphila
has
shown
promise
as
probiotic
for
due
its
roles
in
mucin
degradation
short-chain
fatty
acid
production.
This
study
explores
the
therapeutic
effects
of
on
LPS-induced
mild
dysfunction
mice.
Methods
Thirty-eight
6-week-old
C57BL/6
mice
were
split
into
control
(
n
=
19)
LPS-treated
groups.
received
300
μg/kg/day
LPS
4
weeks,
followed
supplementation
at
41
mg/kg/day
(Akk1)
or
82
(Akk2)
another
weeks.
Gut
microbiota
was
analyzed
via
metagenomic
sequencing,
gene
expression
evaluated
through
transcriptomics.
Results
significantly
altered
microbiota,
reducing
diversity
increasing
pathogenic
genera
like
Lachnoclostridium.
supplementation,
particularly
higher
doses,
partially
restored
beneficial
such
Muribaculum.
Transcriptomics
showed
immune
inflammatory
responses,
while
reduced
these
modulating
pathways
TNF
NF-kappa
B
signaling.
Conclusion
mitigates
restoring
balance
highlighting
potential
agent
health.
Language: Английский
Gut-Vascular Axis and Postbiotics: The Need for Clear Definitions and Further Research
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
208, P. 107405 - 107405
Published: Sept. 11, 2024
Language: Английский
Studies on the Probiotic, Adhesion, and Induction Properties of Artisanal Lactic Acid Bacteria: to Customize a Gastrointestinal Niche to Trigger Anti-obesity Functions
Probiotics and Antimicrobial Proteins,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 9, 2024
Language: Английский
Akkermansia muciniphila- and Pathogenic Bacteria-Derived Endotoxins Differently Regulate Human Dendritic Cell Generation and γδ T Lymphocyte Activation
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(12), P. 1571 - 1571
Published: Dec. 9, 2024
Lipopolysaccharide
(LPS)
is
a
potent
endotoxin
released
at
high
concentrations
in
acute
infections,
causing
massive
host
inflammatory
response.
Accumulating
evidence
indicates
that
dysbiosis-associated
chronic
low
levels
of
circulating
LPS
can
sustain
prolonged
sterile
low-grade
inflammation
increases
the
risk
several
non-communicable
diseases.
Interventions
aimed
increasing
abundance
beneficial/probiotic
bacteria,
including
Akkermansia
muciniphila,
result
reduced
inflammation,
favoring
metabolic
and
immune
health.
Immunosuppression
common
feature
conditions
dendritic
cells
(DCs)
represent
key
targets
given
their
ability
to
shift
balance
toward
immunity
or
tolerance.
In
this
study,
effects
from
pathogenic
(Escherichia
coli
Salmonella
enterica)
probiotic
(Akkermansia
muciniphila)
bacterial
species
on
human
DC
generation
functions
were
compared.
We
report
monocyte
precursor
priming
with
Escherichia
enterica
forces
differentiation
PD-L1-expressing
DCs,
releasing
IL-6
IL-10,
impairs
capacity
drive
full
TCR-Vδ2
T
cell
activation.
Conversely,
comparable
muciniphila
promoted
DCs
preserved
activating
potential
immunostimulatory
properties.
These
results
shed
light
mechanisms
underlying
impact
endotoxemia
disease
pathogenesis,
increase
our
understanding
immunomodulatory
muciniphila.
Language: Английский
Microbiota modifications in prehabilitation – the next step towards comprehensive preparation for surgery. The scoping review
Igor Łoniewski,
No information about this author
Tomasz Banasiewicz,
No information about this author
Jerzy Sieńko
No information about this author
et al.
Gastroenterology Review,
Journal Year:
2024,
Volume and Issue:
19(4), P. 347 - 361
Published: Jan. 1, 2024
This
scoping
review
highlights
the
role
of
microbiota
modifications
in
prehabilitation
for
surgical
patients.
It
emphasises
importance
optimising
gut
through
probiotics,
synbiotics,
and
postbiotics
to
reduce
complications,
such
as
site
infections
(SSIs).
The
that
dysbiosis,
worsened
by
surgery,
stress,
antibiotics,
poor
diet,
can
lead
increased
infection
risk
slower
recovery.
Evidence
from
systematic
reviews,
meta-analyses,
randomised
controlled
trials
suggests
microbiota-targeted
interventions
SSIs,
enhance
immune
responses,
promote
quicker
advocates
an
individualised
approach
prehabilitation,
incorporating
based
on
patient-specific
factors
surgery
type.
However,
it
also
notes
need
further
research
standardise
therapeutic
regimens
confirm
safety
efficacy
these
clinical
practice.
Language: Английский